Structure of the HIV-1 capsid, dynamic 3D surface model The model ... Available in 4K FullHD and HD video Atomic structure of the human herpesvirus 6B capsid with icosahedral symmetry shown Human ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

Lenacapavir, however, is the first drug to disrupt the protective capsid layer surrounding HIV's genetic material (RNA), blocking the virus's ability to reproduce and be transmitted from person to ...

Inset: Interior view a HIV-1 virus showing the capsid (yellow) that surrounds the RNA and enzymes necessary for replication. A multi-national, multi-institutional study led by Weill Cornell ...

Lenacapavir is an HIV capsid inhibitor with a long half-life in the body, meaning it can be administered once every six months. Phase 3 studies showed that it dramatically reduced HIV acquisition in ...

Lenacapavir, however, is the first drug to disrupt the protective capsid layer surrounding HIV’s genetic material (RNA), blocking the virus’s ability to reproduce and be transmitted from person to ...

A move by the Trump administration to freeze funding for the U.S.’s widely heralded international HIV/AIDS program is sowing uncertainty globally and putting countless lives at immediate risk ...